Docusign (NASDAQ:DOCU) Posts Earnings Results, Beats Estimates By $0.09 EPS

Docusign (NASDAQ:DOCU) announced its quarterly earnings results on Thursday. The company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09, FiscalAI reports. The firm had revenue of $830.24 million during the quarter, compared to analysts’ expectations of $824.71 million. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.90 earnings per share.

Here are the key takeaways from Docusign’s conference call:

• DocuSign said Q1 revenue rose 9% year over year to $830 million, with 32% operating margin and 35% free cash flow margin, underscoring durable execution.
• The company highlighted strong momentum in its AI-native IAM platform, with IAM now representing 12.6% of total ARR and management still targeting about 18% of ARR by fiscal year-end.
• Management emphasized growing enterprise adoption and ecosystem expansion, including new integrations with Anthropic, OpenAI, Salesforce, Workday, Coupa, Stripe and others, plus new agentic tools and credit-based platform pricing.
• Underlying customer trends improved, with dollar net retention above 102%, customer count up 9% to nearly 1.9 million, and customers spending over $300,000 in ACV growing 12% year over year to 1,258.
• DocuSign returned capital aggressively, repurchasing $318 million of stock in the quarter — its largest quarterly buyback ever — while maintaining a strong balance sheet with about $1 billion in cash and no debt.

Docusign Stock Down 2.8%

Shares of DOCU traded down $1.46 during trading hours on Thursday, hitting $50.94. The company had a trading volume of 7,035,686 shares, compared to its average volume of 4,356,742. The firm has a market cap of $9.90 billion, a price-to-earnings ratio of 34.42, a PEG ratio of 2.10 and a beta of 0.92. The business has a fifty day moving average of $47.74 and a 200-day moving average of $54.21. Docusign has a 12 month low of $40.16 and a 12 month high of $94.67.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on DOCU shares. Bank of America started coverage on Docusign in a report on Tuesday, March 31st. They set an “underperform” rating and a $52.00 price objective for the company. Morgan Stanley decreased their price target on shares of Docusign from $90.00 to $69.00 and set an “equal weight” rating on the stock in a research note on Wednesday, March 18th. Citigroup downgraded shares of Docusign from a “buy” rating to a “neutral” rating and cut their target price for the company from $99.00 to $50.00 in a research report on Friday, April 10th. UBS Group reduced their price target on Docusign from $75.00 to $54.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 18th. Finally, Robert W. Baird decreased their target price on Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Three analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $61.40.

Insider Buying and Selling

In related news, insider James P. Shaughnessy sold 12,000 shares of Docusign stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $46.83, for a total transaction of $561,960.00. Following the completion of the sale, the insider directly owned 53,631 shares of the company’s stock, valued at approximately $2,511,539.73. This trade represents a 18.28% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Allan C. Thygesen sold 26,250 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $47.78, for a total transaction of $1,254,225.00. Following the transaction, the chief executive officer directly owned 152,237 shares in the company, valued at $7,273,883.86. This represents a 14.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 65,126 shares of company stock valued at $3,107,875 in the last ninety days. 0.59% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Docusign

Several hedge funds and other institutional investors have recently modified their holdings of the business. Smartleaf Asset Management LLC raised its holdings in Docusign by 8.2% in the 2nd quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock worth $166,000 after acquiring an additional 165 shares during the last quarter. Centaurus Financial Inc. raised its position in Docusign by 3.4% in the third quarter. Centaurus Financial Inc. now owns 5,582 shares of the company’s stock worth $402,000 after acquiring an additional 184 shares during the period. Itau Unibanco Holding S.A. raised its position in Docusign by 60.6% in the fourth quarter. Itau Unibanco Holding S.A. now owns 864 shares of the company’s stock worth $59,000 after acquiring an additional 326 shares during the period. Hilltop Holdings Inc. raised its position in Docusign by 2.2% in the third quarter. Hilltop Holdings Inc. now owns 17,028 shares of the company’s stock worth $1,228,000 after acquiring an additional 363 shares during the period. Finally, Vise Technologies Inc. raised its position in Docusign by 12.6% in the fourth quarter. Vise Technologies Inc. now owns 3,501 shares of the company’s stock worth $239,000 after acquiring an additional 393 shares during the period. Institutional investors own 77.64% of the company’s stock.

Docusign declared that its board has approved a stock buyback plan on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 21% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board of directors believes its shares are undervalued.

Docusign News Roundup

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Docusign beat Q1 earnings and revenue estimates, showing continued profitability and steady demand. DocuSign (DOCU) Q1 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management lifted revenue guidance slightly, helped by momentum in its AI-focused agreement platform. DocuSign Nudges Revenue Outlook Higher After First-Quarter Profit Rises
• Neutral Sentiment: Several directors sold small amounts of stock, but the sales were pre-planned under Rule 10b5-1 programs and are not usually viewed as a major signal. SEC filing: Anna Marrs Form 4
• Neutral Sentiment: Investors are also weighing whether Docusign’s AI strategy can translate into faster growth and stronger stock performance going forward. DocuSign Delivers Beat-And-Raise Q1, But Investors Aren’t Impressed

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.